penicillamine has been researched along with lactulose in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Pusch, JH; Ullmann, W | 1 |
Fischer, R; Kalk, JF; Kruck, P; Müting, D | 1 |
Mörl, M | 1 |
2 review(s) available for penicillamine and lactulose
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Long-term treatment of chronic hepatitis and liver cirrhosis].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Chronic Disease; Diagnosis, Differential; Diet Therapy; Dietary Fats; Dietary Proteins; Diuretics; Hepatitis; Humans; Immunosuppressive Agents; Lactulose; Liver Cirrhosis; Liver Diseases; Long-Term Care; Penicillamine; Rest; Vitamin B 12 | 1975 |
4 other study(ies) available for penicillamine and lactulose
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
[Chronic destructive non-suppurating cholangitis].
Topics: Aged; Alkaline Phosphatase; Antibodies, Antinuclear; Autoantibodies; Cholestyramine Resin; Female; gamma-Glutamyltransferase; Humans; Immunoglobulin M; Lactulose; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondria, Liver; Muscle, Smooth; Pectins; Penicillamine; Phenobarbital | 1982 |
[Main characteristics of the treatment of liver cirrhosis].
Topics: Adolescent; Adult; Ascites; Bed Rest; Bloodletting; Child; Child, Preschool; Cholestyramine Resin; Dietary Fats; Dietary Proteins; Diuretics; Energy Intake; Female; Hemochromatosis; Hepatic Encephalopathy; Hepatolenticular Degeneration; Humans; Lactulose; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Penicillamine; Potassium; Vitamin B 12 | 1981 |